文献速递创伤与烧伤重症综合管理与镇静镇痛

治疗前高渗状态对重型颅脑创伤预后的有益影响:来自韩国多中心登记与倾向性评分匹配分析

Beneficial Effect of Pretreatment Hyperosmolality on Outcome in Severe Traumatic Brain Injury: Evidence from a South Korean Multicenter Registry and Propensity Score Matching Analysis.
PubMed 文献 · Neurocrit Care · 2024-07-12
一句话结论韩国多中心登记显示,重型颅脑创伤(GCS<9)治疗前血清渗透压升高与6个月良好功能预后相关(32.5% vs 18.8%,p=0.025)。

研究基于韩国多中心颅脑创伤数据库2016年1月至2018年12月收治的4628例颅脑创伤患者,选取507例重型颅脑创伤(GCS<9)患者,分析治疗前血清渗透压与预后的关系。多因素分析显示治疗前血清渗透压与临床预后显著相关(p<0.001),预测良好预后的最佳截断值为331 mOsm/L(敏感度38.9%、特异度87.7%)。倾向性评分匹配后,治疗前高渗组(渗透压>320 mOsm/L)6个月改良Rankin量表≤3分的比例显著高于非高渗组(32.5% vs 18.8%,p=0.025)。作者认为治疗前血清高渗状态可能对重型颅脑创伤患者具有神经保护作用。

要点

  • 重型颅脑创伤(GCS<9)患者治疗前血清渗透压>320 mOsm/L定义为高渗组,倾向性评分匹配后6个月良好预后(mRS≤3)为32.5% vs 18.8%(p=0.025)。
  • 多因素分析显示治疗前血清渗透压与重型颅脑创伤临床预后显著相关(p<0.001)。
  • 预测6个月良好预后的治疗前血清渗透压最佳截断值为331 mOsm/L,敏感度38.9%、特异度87.7%。
  • 研究纳入韩国多中心颅脑创伤数据库2016年1月至2018年12月收治的4628例颅脑创伤患者中的507例重型颅脑创伤患者。
  • 作者认为治疗前血清高渗状态可能对重型颅脑创伤患者具有神经保护作用。

适用人群与场景

  • 韩国多中心颅脑创伤数据库2016年1月至2018年12月收治的颅脑创伤患者,共4628例,其中507例重型颅脑创伤(Glasgow昏迷量表评分<9)纳入分析。

诊断标准与关键阈值

  • 重型颅脑创伤定义为Glasgow昏迷量表评分<9。
  • 治疗前高渗组定义为治疗前血清渗透压>320 mOsm/L。
  • 良好预后定义为伤后6个月改良Rankin量表评分≤3分。
  • 预测良好预后的治疗前血清渗透压最佳截断值为331 mOsm/L,敏感度38.9%、特异度87.7%。

研究设计与关键结果

  • 研究类型为基于韩国多中心颅脑创伤数据库的分析,纳入4628例颅脑创伤患者中的507例重型颅脑创伤(GCS<9)患者,分析临床、实验室、初始CT和治疗四个数据域。
  • 多因素分析显示治疗前血清渗透压与重型颅脑创伤患者临床预后显著相关(p<0.001)。
  • 预测良好预后的治疗前血清渗透压最佳截断值为331 mOsm/L,敏感度38.9%、特异度87.7%。
  • 倾向性评分匹配分析比较治疗前血清高渗组与非高渗组,高渗组6个月良好功能预后(mRS≤3)为32.5% vs 非高渗组18.8%(p=0.025)。

证据类型、等级与局限

  • 证据类型:基于韩国多中心颅脑创伤数据库的登记研究,采用多因素回归、受试者工作特征曲线分析和倾向性评分匹配分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,治疗前血清高渗状态可能对重型颅脑创伤患者具有神经保护作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hyperosmolar therapy has long been a cornerstone in managing increased intracranial pressure and improving outcomes in severe traumatic brain injury (TBI). This therapy hinges on elevating serum osmolality, creating an osmotic gradient that draws excess water from the brain's cellular and interstitial compartments and effectively reducing cerebral edema. Given this information, we hypothesized that the serum hyperosmolality prior to any treatment could significantly impact the clinical outcomes of patients with severe TBI, potentially mitigating secondary cerebral edema after trauma.

METHODS: Data were extracted from the Korean Multi-center Traumatic Brain Injury data bank, encompassing 4628 patients with TBI admitted between January 2016 and December 2018. Of these, 507 patients diagnosed with severe TBI (Glasgow Coma Scale score < 9) were selected for comprehensive analysis across four data domains: clinical, laboratory, initial computed tomography scan, and treatment. Serum osmolality was assessed prior to treatment, and the hyperosmolar group was defined by a pretreatment serum osmolality exceeding 320 mOsm/L, whereas favorable outcomes were characterized by a modified Rankin Scale score of ≤ 3 at 6 months after trauma. Multivariate regression with receiver operating characteristic curve analysis and propensity score matching were used to dissect the data set.

RESULTS: Multivariate analysis showed serum osmolality is significantly associated with clinical outcome in patients with severe TBI (p < 0.001). The optimal cutoff value for predicting favorable outcome was 331 mOsm/L, with a sensitivity of 38.9% and a specificity of 87.7%. Notably, the propensity score matching analysis comparing patients with pretreatment serum hyperosmolality with those without indicated a markedly improved functional outcome in the former group (32.5% vs 18.8%, p = 0.025).

CONCLUSIONS: The present study has uncovered a significant correlation between the pretreatment serum osmolality and the clinical outcomes of patients with severe TBI. These findings offer a novel perspective, indicating that a serum hyperosmolality prior to any treatment might potentially have a neuroprotective effect in patients with severe TBI.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Roh H, Hwang SY, Kim JH, et al. Beneficial Effect of Pretreatment Hyperosmolality on Outcome in Severe Traumatic Brain Injury: Evidence from a South Korean Multicenter Registry and Propensity Score Matching Analysis. Neurocrit Care. 2024. PMID: 38997449. doi:10.1007/s12028-024-02043-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。